Literature DB >> 20054342

A prevalent mutation with founder effect in xeroderma pigmentosum group C from north Africa.

Nadem Soufir1, Cecile Ged, Agnes Bourillon, Frederic Austerlitz, Cécile Chemin, Anne Stary, Jacques Armier, Daniele Pham, Khadija Khadir, Joelle Roume, Smail Hadj-Rabia, Bakar Bouadjar, Alain Taieb, Hubert de Verneuil, Hakima Benchiki, Bernard Grandchamp, Alain Sarasin.   

Abstract

Xeroderma pigmentosum (XP) is a rare autosomal recessive disorder that is associated with an inherited defect of the nucleotide excision repair pathway (NER). In this study, we investigated the involvement of XP genes in 86 XP patients belonging to 66 unrelated families, most of them consanguineous and originating from Maghreb. Sequencing analysis was performed either directly (44 probands) or after having previously characterized the involved XP gene by complementation assay (22 families). XPC and XPA mutations were respectively present in 56/66 and 8/66 probands. Strikingly, we identified the same homozygous frameshift mutation c.1643_1644delTG (p.Val548AlafsX25) in 87% of XP-C patients. Haplotype analysis showed a common founder effect for this mutation in the Mediterranean region, with an estimated age of 50 generations or 1,250 years. Among 7/8 XP-A patients, we found the previously reported nonsense homozygous XPA mutation (p.Arg228X). Six mutations--to our knowledge previously unreported--(five in XPC, one in XPA) were also identified. In conclusion, XPC appears to be the major disease-causing gene concerning xeroderma pigmentosum in North Africa. As the (p.Val548AlafsX25) XPC mutation is responsible for a huge proportion of XP cases, our data imply an obvious simplification of XP molecular diagnosis, at least in North Africa.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20054342     DOI: 10.1038/jid.2009.409

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  24 in total

1.  Predisposition to hematologic malignancies in patients with xeroderma pigmentosum.

Authors:  Karolyn A Oetjen; Melissa A Levoska; Deborah Tamura; Sawa Ito; Dorothea Douglas; Sikandar G Khan; Katherine R Calvo; Kenneth H Kraemer; John J DiGiovanna
Journal:  Haematologica       Date:  2019-08-22       Impact factor: 9.941

2.  Familial predisposition to TP53/complex karyotype MDS and leukemia in DNA repair-deficient xeroderma pigmentosum.

Authors:  Alain Sarasin; Samuel Quentin; Nathalie Droin; Mourad Sahbatou; Véronique Saada; Nathalie Auger; Yannick Boursin; Philippe Dessen; Anna Raimbault; Vahid Asnafi; Jean-Luc Schmutz; Alain Taïeb; Carlos F M Menck; Filippo Rosselli; Laurianne Drieu La Rochelle; Caroline Robert; Flore Sicre de Fontbrune; Marie Sébert; Thierry Leblanc; Patricia Kannouche; Stéphane De Botton; Eric Solary; Jean Soulier
Journal:  Blood       Date:  2019-03-26       Impact factor: 22.113

3.  DUSP3 maintains genomic stability and cell proliferation by modulating NER pathway and cell cycle regulatory proteins.

Authors:  Lilian Cristina Russo; Jessica Oliveira Farias; Fabio Luis Forti
Journal:  Cell Cycle       Date:  2020-05-07       Impact factor: 4.534

4.  Founder mutations in xeroderma pigmentosum.

Authors:  Deborah Tamura; John J DiGiovanna; Kenneth H Kraemer
Journal:  J Invest Dermatol       Date:  2010-06       Impact factor: 8.551

Review 5.  Therapeutics of xeroderma pigmentosum: A PRISMA-compliant systematic review.

Authors:  Fernando Antônio Gomes de Andrade; Claudio Eduardo de Oliveira Cavalcanti; Felipe Contoli Isoldi; Lydia Masako Ferreira
Journal:  Indian J Dermatol Venereol Leprol       Date:  2021 Mar-Apr       Impact factor: 2.545

6.  Repair of UV photolesions in xeroderma pigmentosum group C cells induced by translational readthrough of premature termination codons.

Authors:  Christiane Kuschal; John J DiGiovanna; Sikandar G Khan; Richard A Gatti; Kenneth H Kraemer
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

7.  The Moroccan Genetic Disease Database (MGDD): a database for DNA variations related to inherited disorders and disease susceptibility.

Authors:  Hicham Charoute; Halima Nahili; Omar Abidi; Khalid Gabi; Hassan Rouba; Malika Fakiri; Abdelhamid Barakat
Journal:  Eur J Hum Genet       Date:  2013-07-17       Impact factor: 4.246

8.  Age-related neuronal degeneration: complementary roles of nucleotide excision repair and transcription-coupled repair in preventing neuropathology.

Authors:  Dick Jaarsma; Ingrid van der Pluijm; Monique C de Waard; Elize D Haasdijk; Renata Brandt; Marcel Vermeij; Yvonne Rijksen; Alex Maas; Harry van Steeg; Jan H J Hoeijmakers; Gijsbertus T J van der Horst
Journal:  PLoS Genet       Date:  2011-12-08       Impact factor: 5.917

9.  Founder mutations in Tunisia: implications for diagnosis in North Africa and Middle East.

Authors:  Lilia Romdhane; Rym Kefi; Hela Azaiez; Nizar Ben Halim; Koussay Dellagi; Sonia Abdelhak
Journal:  Orphanet J Rare Dis       Date:  2012-08-21       Impact factor: 4.123

10.  Thyroid nodules in xeroderma pigmentosum patients: a feature of premature aging.

Authors:  S D Kouatcheu; J Marko; D Tamura; S G Khan; C R Lee; J J DiGiovanna; K H Kraemer
Journal:  J Endocrinol Invest       Date:  2020-11-05       Impact factor: 5.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.